Discovery of Pyrroloaminopyrazoles as Novel PAK Inhibitors

[摘要]：The P21-activated kinases (PAK) are emerging antitumor therapeutic targets. In this paper, we describe the discovery of potent PAK inhibitors guided by structure-based drug design. In addition, the efflux of the pyrrolopyrazole series was effectively reduced by applying multiple medicinal chemistry strategies, leading to a series of PAK inhibitors that are orally active in inhibiting tumor growth in vivo.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内